Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9


Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?

Giacoppo S, Mazzon E.

Neural Regen Res. 2016 Dec;11(12):1896-1899. doi: 10.4103/1673-5374.197125. Review.


Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives.

de Tommaso M, Arendt-Nielsen L, Defrin R, Kunz M, Pickering G, Valeriani M.

Behav Neurol. 2016;2016:7576292. doi: 10.1155/2016/7576292. Epub 2016 Jun 5. Review.


Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C.

Neurol Clin. 2015 Nov;33(4):909-36. doi: 10.1016/j.ncl.2015.07.008. Epub 2015 Sep 8. Review.


Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

Belendiuk KA, Baldini LL, Bonn-Miller MO.

Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7. Review.


The endocannabinoid system: a putative role in neurodegenerative diseases.

Di Iorio G, Lupi M, Sarchione F, Matarazzo I, Santacroce R, Petruccelli F, Martinotti G, Di Giannantonio M.

Int J High Risk Behav Addict. 2013 Dec;2(3):100-6. doi: 10.5812/ijhrba.9222. Epub 2013 Dec 14. Review.


The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Scotter EL, Abood ME, Glass M.

Br J Pharmacol. 2010 Jun;160(3):480-98. doi: 10.1111/j.1476-5381.2010.00735.x. Review.


Cannabinoids in health and disease.

Kogan NM, Mechoulam R.

Dialogues Clin Neurosci. 2007;9(4):413-30. Review.


Dosing medical marijuana: rational guidelines on trial in Washington State.

Aggarwal SK, Kyashna-Tocha M, Carter GT.

MedGenMed. 2007 Sep 11;9(3):52. No abstract available.


The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

Supplemental Content

Support Center